In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

Higher hospitalization rates were associated with several chronic conditions, possibly due to a higher likelihood of ...

Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.

Hospitalization rates from respiratory syncytial virus (RSV) infection rose with age. Also, hospitalizations were more likely among nursing home residents and older adults with other health issues, ...

Risk factors for RSV transmission included index case viral detection 1 week or more after an index case and a household contact age of 12 years or younger. Of 120 sequenced specimens, the main ...

A study from Yale University today in JAMA Network Open reveals substantial protection by the preventive drug nirsevimab ...

A new study published in the Journal of American Medical Association showed that nirsevimab offers protection against a ...

RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six ...

On 12 March 2025, the World Health Organization (WHO) prequalified the first maternal respiratory syncytial virus (RSV) vaccine to protect infants ...

From next Monday, 17 March, free immunisation from respiratory syncytial virus (RSV) will be available to all newborn babies.

Higher hospitalization rates were associated with several chronic conditions, possibly due to a higher likelihood of infection and increased severity of RSV disease. Blood cancer was the chronic ...